|
⚲
|
| Keyboard |
| Brackmann Christoph
✚
|
|
|---|---|
| CIK # | 0002048634 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002048634] | |
| 4 | [0002048634] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Brackmann Christoph | |
| NovoCure Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-04 | Sell | 6,412 | $13.31 | 85,344 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-03 | Grant | 55,137 | $0.00 | |
|
NovoCure Ltd NVCR
Stock Option (Right to Buy) · derivative
|
2026-03-03 | Grant | 80,674 | $0.00 | |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-11-04 | Tax withheld | 7,033 | $12.23 | 86,014 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-07-29 | Buy | 5,000 | $11.60 | 58,000 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-07-29 | Buy | 10,000 | $11.63 | 116,300 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-07-29 | Buy | 5,000 | $11.50 | 57,500 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-03-04 | Grant | 54,975 | $18.19 | 999,995 |
|
NovoCure Ltd NVCR
Stock Options (Right to buy) · derivative
|
2025-03-04 | Grant | 81,499 | $18.19 | 1,482,467 |